Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Buy
56
FHB Quote, Financials, Valuation and Earnings
Last price:
$25.93
Seasonality move
:
-5.05%
Day range:
$25.77 - $26.27
52-week range:
$19.48 - $28.80
Dividend yield:
3.96%
P/E ratio:
14.99x
P/S ratio:
4.22x
P/B ratio:
1.27x
Volume:
359K
Avg. volume:
766.8K
1-year change:
13.84%
Market cap:
$3.4B
Revenue:
$805.3M
EPS (TTM):
$1.75
Analysts' Opinion
-
Consensus RatingFirst Hawaiian has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 5 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $26.38, First Hawaiian has an estimated upside of 0.52% from its current price of $26.24.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $22.00 representing 100% downside risk from its current price of $26.24.
Fair Value
-
According to the consensus of 6 analysts, First Hawaiian has 0.52% upside to fair value with a price target of $26.38 per share.
FHB vs. S&P 500
-
Over the past 5 trading days, First Hawaiian has overperformed the S&P 500 by 2.33% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
First Hawaiian does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
First Hawaiian has grown year-over-year revenues for 1 quarter straight. In the most recent quarter First Hawaiian reported revenues of $201.3M.
Earnings Growth
-
First Hawaiian has grown year-over-year earnings for 1 quarter straight. In the most recent quarter First Hawaiian reported earnings per share of $0.48.
Enterprise value:
477M
EV / Invested capital:
0.16x
Price / LTM sales:
4.22x
EV / EBIT:
0.73x
EV / Revenue:
0.60x
PEG ratio (5yr expected):
--
EV / Free cash flow:
2.17x
Price / Operating cash flow:
15.31x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.92%
Net Income Margin (TTM):
28.24%
Return On Equity:
8.97%
Return On Invested Capital:
7.87%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $722.2M | $813.9M | $797.1M | $194.9M | $201.3M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $1.89 | $2.09 | $1.75 | $0.46 | $0.48 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $882.3M | $2.7B | $4.6B | $4.4B | $3.6B | |
| Total Assets | $22.3B | $25.5B | $24.9B | $24.9B | $23.8B | |
| Current Liabilities | $138.8M | $144.4M | $134M | $599.7M | $350.4M | |
| Total Liabilities | $19.6B | $22.8B | $22.7B | $22.6B | $21.1B | |
| Total Equity | $2.7B | $2.7B | $2.2B | $2.4B | $2.6B | |
| Total Debt | $200M | $200M | -- | -- | $250M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $442.1M | $322.8M | $244.9M | $26.2M | $58.9M | |
| Cash From Investing | -$1.5B | $157.4M | $1.3B | $229M | $273.4M | |
| Cash From Financing | -$394.8M | -$215.7M | -$1.7B | $400.1M | -$374.2M | |
| Free Cash Flow | $426M | $312M | $219.8M | $22.1M | $52.3M | |
FHB
Sector
Market Cap
$3.4B
$698.9M
Price % of 52-Week High
91.11%
88.68%
Dividend Yield
3.96%
2.18%
Shareholder Yield
--
3.87%
1-Year Price Total Return
13.84%
7.42%
Beta (5-Year)
0.983
0.734
Dividend yield:
3.96%
Annualized payout:
$1.04
Payout ratio:
59%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$25.98
200-day SMA
Buy
Level
$23.20
Bollinger Bands (100)
Buy
Level
22.99 - 26.61
Chaikin Money Flow
Sell
Level
-6.7M
20-day SMA
Sell
Level
$26.79
Relative Strength Index (RSI14)
Sell
Level
46.87
ADX Line
Buy
Level
23.49
Williams %R
Neutral
Level
-57.2881
50-day SMA
Sell
Level
$26.29
MACD (12, 26)
Sell
Level
-0.21
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Sell
Level
-46.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4219)
Sell
CA Score
(Annual)
Level (-2.1991)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.5838)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. Its segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.
Stock Forecast FAQ
In the current month, FHB has received 0 Buy ratings 5 Hold ratings, and 1 Sell ratings. The FHB average analyst price target in the past 3 months is $26.38.
-
Where Will First Hawaiian Stock Be In 1 Year?
According to analysts, the consensus estimate is that First Hawaiian share price will rise to $26.38 per share over the next 12 months.
-
What Do Analysts Say About First Hawaiian?
Analysts are divided on their view about First Hawaiian share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that First Hawaiian is a Buy and believe this share price will drop from its current level to $30.00.
-
What Is First Hawaiian's Price Target?
The price target for First Hawaiian over the next 1-year time period is forecast to be $26.38 according to 6 Wall Street analysts, 0 of them rate the stock a Buy, 1 rates the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is FHB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for First Hawaiian is a Hold. 5 of 6 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of FHB?
You can purchase shares of First Hawaiian via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase First Hawaiian shares.
-
What Is The First Hawaiian Share Price Today?
First Hawaiian was last trading at $25.93 per share. This represents the most recent stock quote for First Hawaiian. Yesterday, First Hawaiian closed at $26.24 per share.
-
How To Buy First Hawaiian Stock Online?
In order to purchase First Hawaiian stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.26% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 4.72% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 5.3% over the past day.
